Over 60% of U.S. adults have risk factors for type 2 diabetes, far more than current diabetes prevention programs can realistically serve. Since diabetes often develops gradually ...

Lumo leverages advanced machine learning to reduce calibration time, and flag low-confidence response factor predictions.

Machine learning is changing the front end of drug discovery, where researchers decide which targets to pursue and which molecules deserve costly laboratory work. Its deeper test lies further ...

Researchers at MUSC Hollings Cancer Center have developed a machine learning tool to identify cancer patients who may be at high risk for financial toxicity – the financial stress and hardship that ...

Overview: Enterprises now prioritize scalable AI frameworks supporting automation, governance, and intelligent workflow ...